Special Session-3 Catch-up Development of Made-in-Japan Vaccines!

June 30 (Thur) 10:30 - 12:00

Session Chair Toichi Takenaka, Astellas Pharma Inc.

The Development of the Next Generation Vaccines for Infectious Diseases

[Speaker]
Koichi Yamanishi
Director General
National Institute of Biomedical Innovation(NIBIO)

Abstract
In order to develop the next generation vaccines for infectious diseases, new developments of devices for vaccine inoculation, adjuvants and vectors for recombinant vaccines are expected.  Furthermore, tight collaboration among manufactures, universities and government is necessary to achieve it.


Development of New Recombinant Influenza Vaccines Manufactured by Insect Cell Culture

[Speaker]
Shu-ichi Kanazashi
Chief Executive Officer
UMN Pharma Inc.

Abstract
The Japanese government has focused on the development of cell culture-based pandemic influenza vaccines as a national project. A specific example of our effort as a biotechnology company will be overviewed.


- Please note that the speakers and programs are subject to change.
The photographic and video recording rights are reserved to the Show Management.

About INT'L BIO FORUM & BIO EXPO JAPAN bioexpo@reedexpo.co.jp